AAOS Highlights Need for Early Sarcoma Detection

The American Academy of Orthopaedic Surgeons (AAOS) is emphasizing the importance of early detection for sarcomas, a group of rare bone and soft tissue cancers. During Sarcoma Awareness Month, the organization is alerting patients and healthcare providers to persistent symptoms such as unexplained pain, swelling, or growing lumps that should not be ignored.

An estimated 13,910 new cases of soft tissue sarcoma are projected to be diagnosed in the United States in 2026. Due to the commonality of symptoms resembling less severe conditions like sports injuries, diagnoses are often delayed, potentially impacting treatment outcomes. AAOS notes that the rarity of sarcomas can make them challenging to identify, stressing the need for professional medical evaluation.

This year's awareness efforts coincide with increased governmental focus on sarcoma. A Senate resolution was agreed to on June 9, 2026, supporting the designation of July 2026 as National Sarcoma Awareness Month, signaling growing attention to rare cancer research and patient care.

Sarcoma encompasses over 70 subtypes and typically requires a multidisciplinary team for effective treatment. The AAOS provides patient resources and educational materials on its website, OrthoInfo.org, to help individuals and families navigate the complexities of the disease.